BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24767858)

  • 1. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
    Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
    Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
    Sentani K; Oue N; Sakamoto N; Arihiro K; Aoyagi K; Sasaki H; Yasui W
    Mod Pathol; 2008 Apr; 21(4):464-75. PubMed ID: 18204429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
    Liu X; Sheng W; Wang Y
    J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
    Gao YB; Zhang DF; Jin XL; Xiao JC
    J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
    Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
    Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.
    Liu X; Cheng Y; Sheng W; Lu H; Xu X; Xu Y; Long Z; Zhu H; Wang Y
    Am J Surg Pathol; 2010 Oct; 34(10):1465-71. PubMed ID: 20871221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
    Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
    Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
    Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
    Aizawa K; Motoyama T; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Muto I; Tanaka O; Hatakeyama K
    Int J Cancer; 1994 Aug; 58(3):430-5. PubMed ID: 7519587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Fetoprotein (AFP)-Negative Hepatoid Adenocarcinoma of the Stomach and its Associated Uncommon Features With a Review.
    Rajasekaran P; Pattnaik B; Mishra M; Shahin M; Mishra P; Ayyanar P
    Int J Surg Pathol; 2023 Aug; 31(5):872-878. PubMed ID: 36503302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
    Zhang JF; Shi SS; Shao YF; Zhang HZ
    Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
    Morinaga S; Takahashi Y
    Jpn J Clin Oncol; 1996 Aug; 26(4):258-63. PubMed ID: 8765186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
    He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
    Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic gastrointestinal hepatoid adenocarcinoma of the liver: a high-grade carcinoma that is easily confused with primary hepatocellular carcinoma].
    Lou KX; Fu Y; Wu HY; Wang T; Kwasi ASD; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):710-714. PubMed ID: 32610383
    [No Abstract]   [Full Text] [Related]  

  • 20. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M; Kwok S; Yano H; Pai RK
    Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.